-
1
-
-
0028338424
-
Course of ulcerative colitis: Analysis of changes in disease activity over years
-
Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994;107:3-11.
-
(1994)
Gastroenterology
, vol.107
, pp. 3-11
-
-
Langholz, E.1
Munkholm, P.2
Davidsen, M.3
Binder, V.4
-
2
-
-
0025077719
-
Colonoscopic surveillance in long-standing total ulcerative colitis - A 15-year follow-up study
-
Lfberg R, Karln P, Tribukait B, Ost A. Colonoscopic surveillance in long-standing total ulcerative colitis - a 15-year follow-up study. Gastroenterology 1990;99:1021-31.
-
(1990)
Gastroenterology
, vol.99
, pp. 1021-1031
-
-
Lfberg, R.1
Karln, P.2
Tribukait, B.3
Ost, A.4
-
3
-
-
0025021298
-
Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn's disease
-
Korelitz BI. Considerations of surveillance, dysplasia, and carcinoma of the colon in the management of ulcerative colitis and Crohn's disease. Med Clin North Am 1990;74:189-99.
-
(1990)
Med Clin North Am
, vol.74
, pp. 189-199
-
-
Korelitz, B.I.1
-
4
-
-
0022361675
-
Surveillance for colonic carcinoma in ulcerative colitis
-
Rosenstock E, Farmer RG, Petras R, Sivak MV, Rankin GB, Sullivan BH. Surveillance for colonic carcinoma in ulcerative colitis. Gastroenterology 1985;89:1342-6. (Pubitemid 16228058)
-
(1985)
Gastroenterology
, vol.89
, Issue.6
, pp. 1342-1346
-
-
Rosenstock, E.1
Farmer, R.G.2
Petras, R.3
-
5
-
-
38849113431
-
Colitis and cancer: A tale of inflammatory cells and their cytokines
-
DOI 10.1172/JCI34831
-
Burstein E, Fearon RE. Colitis and cancer: a tale of inflammatory cells and their cytokines. J Clin Invest 2008;118:464-7. (Pubitemid 351206535)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.2
, pp. 464-467
-
-
Burstein, E.1
Fearon, E.R.2
-
6
-
-
35448971037
-
Medical therapy for Crohn's disease: Top-down or step-up?
-
DOI 10.1159/000103897
-
Baert F, Caprilli R, Angelucci E. Medical therapy of Crohn's disease: top-down or step-up. Digest Dis 2007;25:260-6. (Pubitemid 350194180)
-
(2007)
Digestive Diseases
, vol.25
, Issue.3
, pp. 260-266
-
-
Baert, F.1
Caprilli, R.2
Angelucci, E.3
-
7
-
-
49649101871
-
Controversies in the treatment of Crohn's disease: The case for an accelerated step-up treatment approach
-
Sgergill AK, Terdiman JP. Controversies in the treatment of Crohn's disease: the case for an accelerated step-up treatment approach. World J Gastroenterol 2008;14:2670-7.
-
(2008)
World J Gastroenterol
, vol.14
, pp. 2670-2677
-
-
Sgergill, A.K.1
Terdiman, J.P.2
-
8
-
-
0038305753
-
Crohn's disease: Step up or top down therapy
-
Hanauer SB. Crohn's disease: step up or top down therapy. Best Pract Res Clin Gastroenterol 2003;17:131-7.
-
(2003)
Best Pract Res Clin Gastroenterol
, vol.17
, pp. 131-137
-
-
Hanauer, S.B.1
-
9
-
-
79951501790
-
Cellular mechanisms of TNF function in models of inflammation and autoimmunity
-
Apostolaki M, Armaka M, Victoratos P, Kollias G. Cellular mechanisms of TNF function in models of inflammation and autoimmunity. Curr Dir Autoimmun 2010;11:1-26.
-
(2010)
Curr Dir Autoimmun
, vol.11
, pp. 1-26
-
-
Apostolaki, M.1
Armaka, M.2
Victoratos, P.3
Kollias, G.4
-
10
-
-
42649124339
-
TNF: A master switch for inflammation to cancer
-
DOI 10.2741/3066
-
Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front Biosci 2008;13:5094-107. (Pubitemid 351599660)
-
(2008)
Frontiers in Bioscience
, vol.13
, Issue.13
, pp. 5094-5107
-
-
Sethi, G.1
Sung, B.2
Aggarwal, B.B.3
-
11
-
-
37849052961
-
TNFα blockade in human diseases: Mechanisms and future directions
-
Wong M, Ziring D, Korin Y, et al. TNFα blockade in human diseases: mechanisms and future directions. Clin Immunol 2008;126: 121-36.
-
(2008)
Clin Immunol
, vol.126
, pp. 121-136
-
-
Wong, M.1
Ziring, D.2
Korin, Y.3
-
12
-
-
0034754480
-
Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway
-
Lugering A, Schmidt M, Lugering N, Pauels H, Domschke W, Kucharzik T. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspasedependent pathway. Gastroenterology 2001;121:1145-57. (Pubitemid 33022095)
-
(2001)
Gastroenterology
, vol.121
, Issue.5
, pp. 1145-1157
-
-
Lugering, A.1
Schmidt, M.2
Lugering, N.3
Pauels, H.-G.4
Domschke, W.5
Kucharzik, T.6
-
13
-
-
33644508356
-
Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis
-
Yeo M, Kim DK, Park HJ, et al. Loss of transgelin in repeated bouts of ulcerative colitis-induced colon carcinogenesis. Proteomics 2006; 6:1158-65.
-
(2006)
Proteomics
, vol.6
, pp. 1158-1165
-
-
Yeo, M.1
Kim, D.K.2
Park, H.J.3
-
14
-
-
38849171267
-
Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
-
DOI 10.1172/JCI32453
-
Popivanova B, Kitamura K, Wu Y, et al. Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis. J Clin Invest 2008;118:560-70. (Pubitemid 351206546)
-
(2008)
Journal of Clinical Investigation
, vol.118
, Issue.2
, pp. 560-570
-
-
Popivanova, B.K.1
Kitamura, K.2
Wu, Y.3
Kondo, T.4
Kagaya, T.5
Kaneko, S.6
Oshima, M.7
Fujii, C.8
Mukaida, N.9
-
15
-
-
0033975269
-
Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: Lessons from transgenic and knockout mice
-
Watson AJM, Pritchard DM. Lessons from genetically engineered animal models. VII. Apoptosis in intestinal epithelium: lessons from transgenic and knockout mice. Am J Physiol Gastrointest Liver Physiol 2000;278:G1-5.
-
(2000)
Am J Physiol Gastrointest Liver Physiol
, vol.278
-
-
Watson, A.J.M.1
Pritchard, D.M.2
-
16
-
-
0032880168
-
Matrix metalloproteinase levels are elevated in inflammatory bowel disease
-
Baugh MD, Perry MJ, Hollander AP, et al. Matrix metalloproteinase levels are elevated in inflammatory bowel disease. Gastroenterology 1999;117:814-22.
-
(1999)
Gastroenterology
, vol.117
, pp. 814-822
-
-
Baugh, M.D.1
Perry, M.J.2
Hollander, A.P.3
-
17
-
-
34249929951
-
Biological therapies in inflammatory bowel disease: Top-down or bottom-up?
-
Oldenburg B, Hommes D. Biological therapies in inflammatory bowel disease: top-down or bottom-up? Curr Opinion Gastroenterol 2007; 23:395-9.
-
(2007)
Curr Opinion Gastroenterol
, vol.23
, pp. 395-399
-
-
Oldenburg, B.1
Hommes, D.2
-
18
-
-
67149093244
-
Signaling pathway via TNF-α/ NF-κB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis
-
Onizawa M, Nagaishi T, Kanai T, et al. Signaling pathway via TNF-α/ NF-κB in intestinal epithelial cells may be directly involved in colitis-associated carcinogenesis. Am J Physiol Gastrointest Liver Physiol 2009;296:G850-9.
-
(2009)
Am J Physiol Gastrointest Liver Physiol
, vol.296
-
-
Onizawa, M.1
Nagaishi, T.2
Kanai, T.3
-
19
-
-
3042822267
-
Cancer and the chemokine network
-
Balkwill F. Cancer and the chemokine network. Nature Rev Cancer 2004;4:540-50.
-
(2004)
Nature Rev Cancer
, vol.4
, pp. 540-550
-
-
Balkwill, F.1
-
20
-
-
33750497844
-
Inflammation and cancer: How hot is the link?
-
Aggarwal B, Shishodia S, Sandur SK, Pandey MK, Sethi G. Inflammation and cancer: how hot is the link? Biochem Pharmacol 2006; 72:1605-21.
-
(2006)
Biochem Pharmacol
, vol.72
, pp. 1605-1621
-
-
Aggarwal, B.1
Shishodia, S.2
Sandur, S.K.3
Pandey, M.K.4
Sethi, G.5
-
21
-
-
67349162130
-
Tumor necrosis factor and cancer
-
Balkwill F. Tumor necrosis factor and cancer. Nature Rev Cancer 2009;9:361-71.
-
(2009)
Nature Rev Cancer
, vol.9
, pp. 361-371
-
-
Balkwill, F.1
-
22
-
-
0032966506
-
Mast cells are an important cellular source of tumour necrosis factor in human intestinal tissue
-
Bischoff SC, Lorentz A, Schwengberg S, Weier G, Raab R, Manns MP. Mast cells are an important cellular source of tumor necrosis factor α in human intestinal tissue. Gut 1999;44:643-52. (Pubitemid 29195911)
-
(1999)
Gut
, vol.44
, Issue.5
, pp. 643-652
-
-
Bischoff, S.C.1
Lorentz, A.2
Schwengberg, S.3
Weier, G.4
Raab, R.5
Manns, M.P.6
-
23
-
-
0034146319
-
Lessons from genetically engineered animal models IX. Mast cell-deficient mice and intestinal biology
-
Wershil BK. Lessons from genetically engineered animal models IX. Mast cell-deficient mice and intestinal biology. Am J Physiol Gastrointest Liver Physiol 2000;278:G343-8.
-
(2000)
Am J Physiol Gastrointest Liver Physiol
, vol.278
-
-
Wershil, B.K.1
-
24
-
-
0347123433
-
Tumor-educated macrophages promote tumour progression and metastasis
-
Pollard JW. Tumor-educated macrophages promote tumour progression and metastasis. Nature Rev Cancer 2004;4:71-8.
-
(2004)
Nature Rev Cancer
, vol.4
, pp. 71-78
-
-
Pollard, J.W.1
-
25
-
-
0034052970
-
Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: A study of histopathology, B-catenin and p53 expression and the role of inflammation
-
Cooper HS, Murthy S, Kido K, Yoshitake H, Flanigan A. Dysplasia and cancer in the dextran sulfate sodium mouse colitis model. Relevance to colitis-associated neoplasia in the human: a study of histopathology, B-catenin and p53 expression and the role of inflammation. Carcinogenesis 2000;21:757-68.
-
(2000)
Carcinogenesis
, vol.21
, pp. 757-768
-
-
Cooper, H.S.1
Murthy, S.2
Kido, K.3
Yoshitake, H.4
Flanigan, A.5
-
26
-
-
0037404387
-
Colon carcinogenesis in inflammatory bowel disease: Applying molecular genetics to clinical practice
-
Itzkowitz S. Colon carcinogenesis in inflammatory bowel disease: applying molecular genetics to clinical practice. J Clin Gastroenterol 2003;36:S70-4.
-
(2003)
J Clin Gastroenterol
, vol.36
-
-
Itzkowitz, S.1
-
27
-
-
0028122352
-
Mutations in the p53 gene: An early marker of neoplastic progression in ulcerative colitis
-
Brentnall TA, Crispin DA, Rabinovitch PS, et al. Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 1994;107:369-78.
-
(1994)
Gastroenterology
, vol.107
, pp. 369-378
-
-
Brentnall, T.A.1
Crispin, D.A.2
Rabinovitch, P.S.3
-
28
-
-
0035884596
-
Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and β(2)-microglobulin-deficient mouse
-
Sohn KJ, Shah SA, Reid S, et al. Molecular genetics of ulcerative colitis-associated colon cancer in the interleukin 2- and β(2)- microglobulin-deficient mouse. Cancer Res 2001;61:6912-7.
-
(2001)
Cancer Res
, vol.61
, pp. 6912-6917
-
-
Sohn, K.J.1
Shah, S.A.2
Reid, S.3
-
29
-
-
0028979727
-
Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms
-
Tarmin L, Yin J, Harpaz N, et al. Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 1995;55:2035-8.
-
(1995)
Cancer Res
, vol.55
, pp. 2035-2038
-
-
Tarmin, L.1
Yin, J.2
Harpaz, N.3
-
30
-
-
0346606862
-
Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: A cancer-prone chronic inflammatory disease
-
Hussain SP, Amstad P, Raja K, et al. Increased p53 mutation load in noncancerous colon tissue from ulcerative colitis: a cancer-prone chronic inflammatory disease. Cancer Res 2000;60:3333-7. (Pubitemid 30482141)
-
(2000)
Cancer Research
, vol.60
, Issue.13
, pp. 3333-3337
-
-
Hussain, S.P.1
Amstad, P.2
Raja, K.3
Ambs, S.4
Nagashima, M.5
Bennett, W.P.6
Shields, P.G.7
Ham, A.-J.8
Swenberg, J.A.9
Marrogi, A.J.10
Harris, C.C.11
-
31
-
-
2342430807
-
Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium
-
DOI 10.1136/gut.2003.028779
-
Fujii S, Fujimori T, Kawamata H, et al. Development of colonic neoplasia in p53 deficient mice with experimental colitis induced by dextran sulphate sodium. Gut 2004;53:710-6. (Pubitemid 38561450)
-
(2004)
Gut
, vol.53
, Issue.5
, pp. 710-716
-
-
Fujii, S.1
Fujimori, T.2
Kawamata, H.3
Takada, J.4
Kitajima, K.5
Omotehara, F.6
Kaihara, T.7
Kusaka, T.8
Ichikawa, K.9
Ohkura, Y.10
Ono, Y.11
Imura, J.12
Yamaoka, S.13
Sakamoto, C.14
Ueda, Y.15
Chiba, T.16
-
32
-
-
35648983903
-
Inflammation and cancer: An ancient link with novel potentials
-
Hussain SP, Harris CC. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007;121:2373-80.
-
(2007)
Int J Cancer
, vol.121
, pp. 2373-2380
-
-
Hussain, S.P.1
Harris, C.C.2
-
33
-
-
18844439381
-
Helicobacter pylori and gastric cancer: A new paradigm for inflammation-associated epithelial cancers
-
DOI 10.1053/j.gastro.2005.03.037, PII S0016508505004634
-
Houghton J, Wang TC. Helicobacter pylori and gastric cancer: a new paradigm for inflammation-associated epithelial cancers. Gastroenterology 2005;128:1567-78. (Pubitemid 40692553)
-
(2005)
Gastroenterology
, vol.128
, Issue.6
, pp. 1567-1578
-
-
Houghton, J.1
Wang, T.C.2
-
34
-
-
0037357426
-
Oxidative stress and ulcerative colitis-associated carcinogenesis: Studies in humans and animal models
-
DOI 10.1093/carcin/24.3.353
-
Seril DN, Liao J, Yang GY, Yang CS. Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 2003;24:353-62. (Pubitemid 36432628)
-
(2003)
Carcinogenesis
, vol.24
, Issue.3
, pp. 353-362
-
-
Seril, D.N.1
Liao, J.2
Yang, G.-Y.3
Yang, C.S.4
-
35
-
-
70350513270
-
Regulation of tissue homeostasis by NF-κB signaling: Implications for inflammatory diseases
-
Pasparkis M. Regulation of tissue homeostasis by NF-κB signaling: implications for inflammatory diseases. Nature Rev Immunol 2009;9: 778-88.
-
(2009)
Nature Rev Immunol
, vol.9
, pp. 778-788
-
-
Pasparkis, M.1
-
36
-
-
67749117934
-
Signal integration by JNK and p38 MAPK pathways in cancer development
-
Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nature Rev Cancer 2009;9: 537-49.
-
(2009)
Nature Rev Cancer
, vol.9
, pp. 537-549
-
-
Wagner, E.F.1
Nebreda, A.R.2
-
37
-
-
0029004771
-
Chimeric anti-TNFα monoclonal antibody cA2 binds recombinant transmembrane TNF α and activates immune effector functions
-
Scallon BJ, Moore MA, Trinh H, Knight DM, Ghrayeb J. Chimeric anti-TNFα monoclonal antibody cA2 binds recombinant transmembrane TNF α and activates immune effector functions. Cytokine 1995;7: 251-9.
-
(1995)
Cytokine
, vol.7
, pp. 251-259
-
-
Scallon, B.J.1
Moore, M.A.2
Trinh, H.3
Knight, D.M.4
Ghrayeb, J.5
-
38
-
-
0024314554
-
Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis
-
Brennan FM, Chantry D, Jackson A, Maini R, Feldmann M. Inhibitory effect of TNFα antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet 1989;2:244-7. (Pubitemid 19180612)
-
(1989)
Lancet
, vol.2
, Issue.8657
, pp. 244-247
-
-
Brennan, F.M.1
Jackson, A.2
Chantry, D.3
Maini, R.4
Feldmann, M.5
-
40
-
-
25144490062
-
Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands
-
DOI 10.1186/1471-2407-5-46
-
Kohno H, Suzuki R, Sugie S, Tanaka T. Suppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligands. BMC Cancer 2005;5:46. (Pubitemid 41461083)
-
(2005)
BMC Cancer
, vol.5
, pp. 46
-
-
Kohno, H.1
Suzuki, R.2
Sugie, S.3
Tanaka, T.4
-
41
-
-
44349126693
-
Colon crypt organization and tumorigenesis
-
Humphries A, Wright NA. Colon crypt organization and tumorigenesis. Nature Rev Cancer 2008;8:415-24.
-
(2008)
Nature Rev Cancer
, vol.8
, pp. 415-424
-
-
Humphries, A.1
Wright, N.A.2
-
42
-
-
1942439909
-
Tumor formation is correlated with expression of β -catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice
-
DOI 10.1111/j.1349-7006.2004.tb03209.x
-
Hata K, Yamada Y, Kuno T, et al. Tumor formation is correlated with expression of β-catenin-accumulated crypts in azoxymethane-induced colon carcinogenesis in mice. Cancer Sci 2004;95:316-20. (Pubitemid 38519471)
-
(2004)
Cancer Science
, vol.95
, Issue.4
, pp. 316-320
-
-
Hata, K.1
Yamada, Y.2
Kuno, T.3
Hirose, Y.4
Hara, A.5
Qiang, S.H.6
Mori, H.7
-
43
-
-
0035080617
-
The risk of colorectal cancer in ulcerative colitis: A meta-analysis
-
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001;48:526-35.
-
(2001)
Gut
, vol.48
, pp. 526-535
-
-
Eaden, J.A.1
Abrams, K.R.2
Mayberry, J.F.3
-
44
-
-
0036742876
-
Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid
-
Bernstaein CN, Eaden J, Steinhart AH, Munkholm P, Gordon PH. Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid. Inflamm Bowel Dis 2002;8:356-61.
-
(2002)
Inflamm Bowel Dis
, vol.8
, pp. 356-361
-
-
Bernstaein, C.N.1
Eaden, J.2
Steinhart, A.H.3
Munkholm, P.4
Gordon, P.H.5
-
45
-
-
35948935272
-
5-Aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model
-
DOI 10.1158/1078-0432.CCR-07-1208
-
Ikeda I, Tomimoto A, Wada K, et al. 5-Aminosalicylic acid given in the remission stage of colitis suppresses colitis-associated cancer in a mouse colitis model. Clin Cancer Res 2007;13:6527-31. (Pubitemid 350075044)
-
(2007)
Clinical Cancer Research
, vol.13
, Issue.21
, pp. 6527-6531
-
-
Ikeda, I.1
Tomimoto, A.2
Wada, K.3
Fujisawa, T.4
Fujita, K.5
Yonemitsu, K.6
Nozaki, Y.7
Endo, H.8
Takahashi, H.9
Yoneda, M.10
Inamori, M.11
Kubota, K.12
Saito, S.13
Nagashima, Y.14
Nakagama, H.15
Nakajima, A.16
|